Drug Registration and Acceptance

Drug Name

Exact

Active Ingredient

Acceptance No.

Manufacturers

Acceptance Date

Status Date

Classification

Review Status

Drug Type

Submission

Evaluation Conclusion

ATC Category

Special Approval Varieties

Task Type

Major Special Varieties

Sequence No.

Stock Code

Visualized Analysis Export Evaluation Conclusion Evaluation Progress

Acceptance No.	Drug Name	Dosage Form	Classification	Submission	Acceptance Date	Manufacturers	Manufacturers	Review Status	Status Date	View
CXSB2101004	重组人血管内皮生长因子受体-抗体-人补体受体1融合蛋白注射液	Injection	Biological Products(1)	Supplementary Application	2021-04-14		Innovent Biologics (Suzhou) Co Ltd			view
CXSL1500008	重组人血管内皮生长因子受体-抗体-人补体受体1融合蛋白注射液	Injection	Biological Products(1)	New Drug Application	2015-04-21	信达生物制药（苏州）有限公司	Innovent Biologics (Suzhou) Co Ltd	Certificate Issued	2016-12-22	view
CXSL1500009	重组人血管内皮生长因子受体-抗体-人补体受体1融合蛋白注射液	Injection	Biological Products(1)	New Drug Application	2015-04-21	信达生物制药（苏州）有限公司	Innovent Biologics (Suzhou) Co Ltd	Certificate Issued	2016-12-22	view